comparemela.com
Home
Live Updates
Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis : comparemela.com
Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
EQS-News: ABIVAX
/ Key word: Study results
Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
17.04.2023 / 18:00... | April 17, 2023
Related Keywords
France
,
Paris
,
France General
,
New York
,
United States
,
Enregistrement Universel
,
Hartmutj Ehrlich
,
Sheldon Sloan
,
Pbruce Sands
,
Burrillb Crohn
,
Icahn School Of Medicine At Mount Sinai
,
Steering Committee For The Phase
,
Euronext
,
Euronext Paris
,
Icahn School
,
Mount Sinai
,
Mount Sinai Health System
,
Steering Committee
,
Mayo Score
,
Truffle Capital
,
Although Abivax
,
French Autorit
,
Des March
,
Modified Mayo Score
,
Abivax Stock Exchange
,
News
,
Information
,
Press Release
,
Key
,
Study
,
Reports
,
Efficacy
,
End
,
Safety
,
Data
,
F
,
Obefazimod
,
Hase
,
Tb
,
Maintenance
,
Trial
,
N
,
Ulcerative
,
Olitis Abvx Fr0012333284
,
comparemela.com © 2020. All Rights Reserved.